Switzerland approves use of Pfizer vaccine

“The data that is available so far showed a comparable high level of efficiency in all researched age groups, thus meeting the required”, says the official website of this organ.

“Patient security is the basic prerequisite, especially when it comes to authorising vaccines”, said Scysmedic regulator director Raimund Bruhini.

He said the country was soon achieved thanks to the flexibility of organised teams, at the same time achieving the three main requirements of security, efficiency and quality, Reuters writes.

Switzerland is also considering the adoption of two other vaccines against Coronavirus, that of the American company “Moderna”, which has already been approved for use in the US, as well as the vaccine of the British company “AsterZeneca”.